Zomedica Stock Forecast for 2022 - 2025 - 2030
Updated on 05/19/2022
Based on the current earnings figures, this year's price targets for Zomedica were recently set by zero distinguished experts, with an average mark of $0.00. If it reached this goal, it would represent a potential downside of approximately 0 from the previous closing price in January, 2022. The high end is $0.00, and the low is $0.00.
N/A
Zomedica Price Forecast for 2022 - 2025 - 2030
Over the last three years, Zomedica's Price has increased by 100%, going from $0.00 to $0.00. In the next year, analysts are expecting a significant increase in EPS, predicting it will reach $0.31 – an increase of 100%. The 2030 forecast is for Price to reach $0.72 or grow by 100%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts |
|---|
Zomedica Free Cash Flow Forecast for 2022 - 2025 - 2030
In the past three years, Zomedica's Free Cash Flow has significantly grown, increasing from $-11.78 to $-14.43 – a growth of 22.5%. The next year, 0 experts forecast that Zomedica's Free Cash Flow will decrease by 5.21%, reaching $-14.61. Over the next nine years, experts anticipate that ZOM's Free Cash Flow will grow at a rate of 1.24%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts |
|---|
Zomedica Net Income Forecast for 2022 - 2025 - 2030
Zomedica's Net Income has increased by 10.39% in the last three years, going from $-16.65 to $-18.38. In the following year, the 0 analysts surveyed believe that ZOM's Net Income will decrease by 2.28%, reaching a dismal $-18.17. According to professionals, by 2030, Zomedica's Net Income will have decreased by 1.14%, falling all the way down to $-18.17.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts |
|---|
Zomedica EBITDA Forecast for 2022 - 2025 - 2030
In the last three years, Zomedica's EBITDA has grown by 23.58%, from $-16.37 to $-20.23. According to the 0 analysts polled, in the next year, ZOM's EBITDA will fall by 5.4%, reaching a lowly $-19.07. By 2030, professionals believe that Zomedica's EBITDA will have decreased by an astonishing 5.75%, plummeting to just $-19.07.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts |
|---|
Zomedica EBIT Forecast for 2022 - 2025 - 2030
In the past three years, Zomedica's EBIT has seen a tremendous increase, going from $-16.58 to $-21.37 – an increase of 28.89%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts |
|---|
Zomedica EPS Price Prediction Forecast for 2022 - 2025 - 2030
In the past three years, Zomedica's EPS has decreased by 72.22%, going from $-0.18 to only $-0.05. In the next year, analysts are expecting a significant increase in EPS, predicting it will reach $-0.10 – an increase of 91.58%. The 2030 forecast is for EPS to reach $-0.11 or grow by 125.86%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts |
|---|